The Texas Legislature is pushing for insurance to pay for biomarker testing

When Rebecca Munoz was diagnosed at age 29 with breast cancer in 2017, it was a confusing time. She discovered her lump by accident. She knew nothing about breast cancer treatment and biomarker testing or anything that could improve her outcome.

“It’s almost like a bomb has been dropped on you,” she said. “I thought it was a death sentence.”

She went through six rounds of chemotherapy, a double mastectomy and then immunotherapy before being cancer free.

Munoz was lucky. The biopsy from her tumor was sent for biomarker testing, which looks at the genes, proteins and other characteristics of that tumor to allow doctors to make more individualized and effective treatment decisions.

Leave a Comment

Your email address will not be published. Required fields are marked *